Mobilization of Autologous Hematopoietic Progenitors and Subsequent Transplantation is a Safe and Feasible Procedure in Chronic Phase Chronic Myelogenous Leukemia patients presenting a Cytogenetic Resistance to Imatinib

被引：0
|
作者：
Prebet, Thomas [1 ]
Tigaud, Isabelle [2 ]
Hayette, Sandrine [2 ]
Clapisson, Gilles [3 ]
Philip, Irene [3 ]
Michallet, Mauricette [1 ]
Nicolini, Franck E. [1 ]
机构：
[1] Hop Edouard Herriot, Hematol Dept, 5 Pl Arsonval, F-69437 Lyon 03, France
[2] Ctr Hosp Lyon Sud, Lab Hematol & Cytogenet, Pierre Benite, France
[3] Ctr Leon Berard, Cellular Therapy & Hematopoiet Stem Cell Transpla, Lyon, France
来源：
HAEMATOLOGICA | 2005年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：102 / 103
页数：2
相关论文
共 50 条
  • [1] Autologous hemopoietic progenitors transplantation in chronic myelogenous leukemia
    Carreras, E
    MEDICINA CLINICA, 1997, 109 (05): : 181 - 185
  • [2] Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib
    A Hochhaus
    M Baccarani
    M Deininger
    J F Apperley
    J H Lipton
    S L Goldberg
    S Corm
    N P Shah
    F Cervantes
    R T Silver
    D Niederwieser
    R M Stone
    H Dombret
    R A Larson
    L Roy
    T Hughes
    M C Müller
    R Ezzeddine
    A M Countouriotis
    H M Kantarjian
    Leukemia, 2008, 22 : 1200 - 1206
  • [3] Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib
    Hochhaus, A.
    Baccarani, M.
    Deininger, M.
    Apperley, J. F.
    Lipton, J. H.
    Goldberg, S. L.
    Corm, S.
    Shah, N. P.
    Cervantes, F.
    Silver, R. T.
    Niederwieser, D.
    Stone, R. M.
    Dombret, H.
    Larson, R. A.
    Roy, L.
    Hughes, T.
    Mueller, M. C.
    Ezzeddine, R.
    Countouriotis, A. M.
    Kantarjian, H. M.
    LEUKEMIA, 2008, 22 (06) : 1200 - 1206
  • [4] Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment
    Bhatia, R
    Holtz, M
    Niu, N
    Gray, R
    Snyder, DS
    Sawyers, CL
    Arber, DA
    Slovak, ML
    Forman, SJ
    BLOOD, 2003, 101 (12) : 4701 - 4707
  • [5] Autologous hematopoietic cell transplantation for chronic myelogenous leukemia
    Bhatia, R
    McGlave, PB
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2004, 18 (03) : 715 - +
  • [6] Mobilization of hematopoietic progenitors in patients with chronic myeloid leukemia
    Thijsen, SFT
    Schuurhuis, GJ
    vanOostveen, JW
    Theijsmeijer, AP
    Niewint, AWM
    Ossenkoppele, GJ
    BONE MARROW TRANSPLANTATION, 1997, 20 (10) : 835 - 842
  • [7] Mobilization of hematopoietic progenitors in patients with chronic myeloid leukemia
    SFT Thijsen
    GJ Schuurhuis
    JW van Oostveen
    AP Theijsmeijer
    AWM Niewint
    GJ Ossenkoppele
    Bone Marrow Transplantation, 1997, 20 : 835 - 842
  • [8] Imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in the accelerated phase
    Jiang, Qian
    Xu, Lan-Ping
    Liu, Dai-Hong
    Liu, Kai-Yan
    Chen, Shan-Shan
    Jiang, Bin
    Jiang, Hao
    Chen, Huan
    Chen, Yu-Hong
    Han, Wei
    Zhang, Xiao-Hui
    Wang, Yu
    Qin, Ya-Zhen
    Liu, Yan-Rong
    Lai, Yue-Yun
    Huang, Xiao-Jun
    BLOOD, 2011, 117 (11) : 3032 - 3040
  • [9] Nilotinib is highly active and safe in chronic phase chronic myelogenous leukemia (CML-CP) patients with imatinib-resistance or intolerance
    Kantarjian, Hagop M.
    Hochhaus, Andreas
    Cortes, Jorge
    Martinelli, Giovanni
    Bhalla, Kapil N.
    Giles, Francis J.
    Ossenkoppele, Gert
    Gattermann, Norbert
    Haque, Ariful
    Gallagher, Neil
    Baccarani, Michele
    le Coutre, Philipp
    BLOOD, 2007, 110 (11) : 226A - 226A
  • [10] Resistance to imatinib among patients in chronic phase (CP) of chronic myelogenous leukemia (CML) in clinical practice
    Davis, C.
    Sanders, L.
    Hirji, I.
    Oliveria, S.
    Willey, V. J.
    Phillips, S.
    Yood, M. Ulcickas
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345